Advancedmolecular biology
Alternative Splicing: One Gene, Many Proteins
Overview
Human genes are mosaics of exons and introns — and the spliceosome does not always assemble them the same way. Alternative splicing produces multiple distinct mRNAs from a single gene by including or skipping exons. This lesson explains the splicing mechanisms, their regulation, and why this process is central to protein diversity and disease.
Learning objectives
- Describe the basic splicing reaction: introns out, exons joined.
- List the main patterns of alternative splicing.
- Explain how splicing is regulated by splicing factors.
- Explain how alternative splicing expands the proteome.
- Describe how splicing errors cause disease.
Introns out, exons together
Most eukaryotic genes are split: coding exons interrupted by non-coding introns. After transcription, the spliceosome — a complex of small nuclear RNAs and proteins — cuts out introns and joins exons into continuous mRNA. Constitutive splicing joins every exon the same way each time; alternative splicing varies which exons are kept, producing different messages from one gene.
Recognize intron boundaries (GU at the start, AG at the end), cut introns out as lariats, and ligate the flanking exons — with single-nucleotide precision.
The patterns of variation
Five common patterns generate diversity: exon skipping (an exon included or dropped), alternative 5' or 3' splice sites (trimming an exon's edge), intron retention (an intron kept in the message), and mutually exclusive exons (a choice between two exons). A gene with several variable exons can theoretically produce dozens of isoforms — combinatorial protein design from a single locus.
Regulation: who decides
Splicing choices are controlled by RNA-binding proteins — activators like SR proteins and repressors like hnRNPs — that bind regulatory sequences near splice sites and tip the spliceosome's decision. Because these factors differ between tissues and developmental stages, the same gene produces different isoforms in brain versus muscle, or in embryo versus adult. Splicing is a regulated decision, not a coin flip.
Diversity and disease
Alternative splicing is a major engine of proteome complexity: the majority of human multi-exon genes are alternatively spliced. When splicing goes wrong, the consequences are severe — spinal muscular atrophy stems from mis-splicing of the SMN2 gene, and many cancers show characteristic splicing alterations. Therapies that redirect splicing, such as antisense oligonucleotides, are now clinical reality for some of these diseases.
The brain expresses some of the most complex splicing patterns known — a clue to why splicing regulation is critical for neural function.
Splicing in the bigger picture
Alternative splicing helps resolve the genome-proteome paradox: ~20,000 genes, far more proteins. Combined with post-translational modification, it means the gene is less a blueprint for one protein than a parts kit for a protein family. Understanding any gene's function increasingly means cataloging its isoforms, not just its sequence.
Key points
- Splicing removes introns and joins exons; alternative splicing varies the combination.
- Patterns include exon skipping, alternative splice sites, and intron retention.
- SR proteins and hnRNPs regulate tissue-specific splicing choices.
- Most human multi-exon genes are alternatively spliced.
- Splicing errors cause diseases; splicing-modulating drugs are emerging therapies.
Common misconceptions
✓ Truth: Alternative splicing routinely generates multiple distinct mRNAs — and protein isoforms — from a single gene.
✓ Truth: Introns enable alternative splicing and contain regulatory sequences; their removal is a precisely regulated process, not garbage disposal.
Practice questions
Q1. Exon skipping is a pattern of alternative splicing in which:
- introns are retained
- an exon is either included in or excluded from the mRNA
- the gene is duplicated
- transcription stops early
Exon skipping — the cassette-exon pattern — produces two isoforms differing by exactly one exon's presence.
Q2. The spliceosome recognizes intron boundaries primarily through:
- promoter sequences
- conserved GU-AG dinucleotides and a branch point
- start codons
- poly-A tails
The near-universal GU at the 5' splice site and AG at the 3' site, plus the branch-point adenosine, define where cutting occurs.
Q3. Tissue-specific protein isoforms from the same gene most directly result from:
- different genomes
- regulated alternative splicing
- different ribosomes
- random mutation
Different splicing-factor profiles in each tissue drive different exon choices, yielding distinct isoforms from one gene.
Click a question to reveal the answer and explanation.
Frequently asked questions
What is alternative splicing?
The regulated process by which different combinations of exons from a single gene are joined into mRNA, producing multiple distinct transcripts and protein isoforms from one locus.
How does the spliceosome know where to cut?
It recognizes conserved boundary sequences — typically GU at the intron's 5' end and AG at its 3' end — plus a branch-point sequence, cutting the intron out as a lariat and ligating the exons.
What controls which exons are included?
RNA-binding splicing factors (activators like SR proteins, repressors like hnRNPs) bind near splice sites and influence the spliceosome's choices, with different factor profiles in different tissues.
How can splicing errors cause disease?
Mis-splicing can skip essential exons or include harmful ones, producing defective proteins. Spinal muscular atrophy, for example, involves mis-splicing of SMN2 — now treated with drugs that correct the splicing.